Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Dallah Healthcare Gelecekteki Büyüme
Future kriter kontrolleri 2/6
Dallah Healthcare kazanç ve gelirin sırasıyla yıllık 13.9% ve 11% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 12.6% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 16.4% olacağı tahmin edilmektedir.
Anahtar bilgiler
13.9%
Kazanç büyüme oranı
12.6%
EPS büyüme oranı
| Healthcare kazanç büyümesi | 14.9% |
| Gelir büyüme oranı | 11.0% |
| Gelecekteki özkaynak getirisi | 16.4% |
| Analist kapsamı | Good |
| Son güncelleme | 18 Sep 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?
Sep 19
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 14The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)
Jul 18Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist
May 30We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Apr 16What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E
Mar 18Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes
Feb 25Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward
Oct 30Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return
Jul 26Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)
Apr 17Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Feb 06Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends
Dec 05We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Nov 01Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)
Aug 28Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger
Aug 12Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Jul 28Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%
May 26Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)
May 20Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Apr 16Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Feb 03Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Jan 10Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Oct 19Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically
Jun 16Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher
May 02What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?
Mar 17Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?
Mar 02Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year
Feb 15Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?
Feb 01Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 05
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price
Dec 22Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?
Nov 20Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2026 | 4,070 | 607 | 418 | 774 | 10 |
| 12/31/2025 | 3,723 | 498 | 332 | 676 | 10 |
| 12/31/2024 | 3,291 | 485 | 300 | 652 | 8 |
| 6/30/2024 | 3,105 | 444 | 326 | 667 | N/A |
| 3/31/2024 | 3,010 | 385 | 415 | 724 | N/A |
| 12/31/2023 | 2,943 | 360 | 329 | 626 | N/A |
| 9/30/2023 | 2,831 | 325 | 348 | 562 | N/A |
| 6/30/2023 | 2,682 | 270 | 369 | 549 | N/A |
| 3/31/2023 | 2,595 | 286 | 333 | 519 | N/A |
| 12/31/2022 | 2,488 | 274 | 267 | 442 | N/A |
| 9/30/2022 | 2,370 | 305 | 214 | 367 | N/A |
| 6/30/2022 | 2,313 | 311 | 122 | 260 | N/A |
| 3/31/2022 | 2,220 | 289 | 166 | 290 | N/A |
| 12/31/2021 | 2,105 | 259 | 246 | 362 | N/A |
| 9/30/2021 | 1,935 | 202 | 178 | 305 | N/A |
| 6/30/2021 | 1,742 | 206 | 240 | 363 | N/A |
| 3/31/2021 | 1,498 | 165 | 110 | 215 | N/A |
| 12/31/2020 | 1,318 | 132 | 54 | 183 | N/A |
| 9/30/2020 | 1,257 | 150 | 82 | 211 | N/A |
| 6/30/2020 | 1,207 | 123 | 35 | 198 | N/A |
| 3/31/2020 | 1,246 | 131 | 33 | 244 | N/A |
| 12/31/2019 | 1,252 | 147 | 106 | 307 | N/A |
| 9/30/2019 | 1,227 | 110 | 88 | 290 | N/A |
| 6/30/2019 | 1,206 | 115 | 43 | 264 | N/A |
| 3/31/2019 | 1,193 | 119 | 5 | 255 | N/A |
| 12/31/2018 | 1,181 | 142 | -51 | 204 | N/A |
| 9/30/2018 | 1,189 | 172 | -158 | 184 | N/A |
| 6/30/2018 | 1,203 | 217 | -131 | 253 | N/A |
| 3/31/2018 | 1,218 | 268 | N/A | 297 | N/A |
| 12/31/2017 | 1,212 | 295 | N/A | 353 | N/A |
| 9/30/2017 | 1,202 | 284 | N/A | 457 | N/A |
| 6/30/2017 | 1,180 | 268 | N/A | 387 | N/A |
| 3/31/2017 | 1,181 | 252 | N/A | 382 | N/A |
| 12/31/2016 | 1,163 | 225 | N/A | 343 | N/A |
| 9/30/2016 | 1,122 | 228 | N/A | 244 | N/A |
| 6/30/2016 | 1,073 | 194 | N/A | 261 | N/A |
| 3/31/2016 | 1,030 | 175 | N/A | 233 | N/A |
| 12/31/2015 | 985 | 165 | N/A | 214 | N/A |
| 9/30/2015 | 948 | 161 | N/A | 204 | N/A |
| 6/30/2015 | 917 | 156 | N/A | 168 | N/A |
| 3/31/2015 | 892 | 154 | N/A | 151 | N/A |
| 12/31/2014 | 859 | 147 | N/A | 149 | N/A |
| 9/30/2014 | 831 | 149 | N/A | 137 | N/A |
| 6/30/2014 | 805 | 149 | N/A | 138 | N/A |
| 3/31/2014 | 773 | 138 | N/A | 108 | N/A |
| 12/31/2013 | 750 | 137 | N/A | 102 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 4004 'nin tahmini kazanç büyümesi (yıllık 13.9% ) tasarruf oranının ( 14.5% ) altındadır.
Kazançlar ve Piyasa: 4004 şirketinin kazançlarının (yıllık 13.9% ) SA pazarından (yıllık 7.3% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: 4004 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.
Gelir ve Pazar: 4004 şirketinin gelirinin (yıllık 11% ) SA pazarından (yıllık 1.2% ) daha hızlı büyümesi öngörülüyor.
Yüksek Büyüme Geliri: 4004 şirketinin gelirinin (yıllık 11% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 4004 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 16.4 %).